Patent US5032678A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5032678A Expired / Lapsed US ⏱️ 0.0 years remaining

Radio labeled high molecular compound comprising unit of asialoglycoprotein acceptor-directing compound and unit of chelate forming compound chemically bonded thereto

Assignee: Nihon Medi Physics Co Ltd
•
Filing: 1987-12-30
•
Granted: 1991-07-16
•
Expires: 2007-12-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A high molecular compound useful as a non-radioactive carrier, which comprises at least one unit of (1) an asialoglycoprotein acceptor-directing compound and at least one unit of (2) a chelate-forming compound chemically bonded thereto, and which may be labeled with a radioactive metallic element to give a radioactive metallic element-labeled product useful as a radioactive diagnostic or therapeutic agent for liver.

Inventors

  • 👤 Komei Washino
  • 👤 Miki Kurami
  • 👤 Nobuo Ueda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 11:37
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/08; A61K51/088; A61K51/0491; A61K51/081; A61K2121/00; A61K2123/00

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 62 words
A radioactive metallic element-labeled high molecular compound useful as a nuclear medicine, which consists of at least one unit of (1) an asialoglycoprotein acceptor-directing compound selected from the group consisting of asialofetuin, asialocelluloplasmin, asialohaptoglobin, and galactose-bonded polyglucosamine, at least one unit of (2) a chelate-forming compound chemically bonded thereto and (3) at least one radioactive metallic element chelate-bonded to said chelate-forming compound.
Claim 2
Dependent Claim 62 words
A radioactive metallic element-labeled high molecular compound useful as a nuclear medicine, which consists of at least one unit of (1) an asialoglycoprotein acceptor-directing compound selected from the group consisting of asialofetuin, asialocelluloplasmin, asialohaptoglobin, and galactose-bonded polyglucosamine, at least one unit of (2) a chelate-forming compound chemically bonded thereto and (3) at least one radioactive metallic element chelate-bonded to said chelate-forming compound.
Claim 3
Dependent Claim 14 words
The labeled compound according to claim 1, wherein the chelate-forming compound is diethylenetriaminepentaacetic acid.
Claim 4
Dependent Claim 14 words
The labeled compound of claim 2 wherein the radioactive metallic element is 99m Tc.
Claim 5
Dependent Claim 61 words
A process for preparing a radioactive metallic element-labeled compound, which comprises reacting a compound which consists of at least one unit of (1) an asialoglycoprotein acceptor-directing compound selected from the group consisting of asialofetuin, asialocelluloplasmin, asialohaptoglobin, and galactose-bonded polyglucosamine, and at least one unit of (2) a chelate forming compound chemically bonded thereto, with at least one radioactive metallic element (3).
Claim 6
Dependent Claim 61 words
A process for preparing a radioactive metallic element-labeled compound, which comprises reacting a compound which consists of at least one unit of (1) an asialoglycoprotein acceptor-directing compound selected from the group consisting of asialofetuin, asialocelluloplasmin, asialohaptoglobin, and galactose-bonded polyglucosamine, and at least one unit of (2) a chelate forming compound chemically bonded thereto, with at least one radioactive metallic element (3).
Claim 7
Dependent Claim 13 words
The process according to claim 4, wherein the chelate-forming compound is diethylenetriaminepentaacetic acid.
Claim 8
Dependent Claim 14 words
The process according to claim 5 wherein the radioactive metallic element is 99m Tc.

References Cited (Backward Citations)

US4010251A Cited
EP0024464A1 Cited
US4287362A Cited
US4338248A Cited
US4401647A Cited
US4735210A Cited
EP0233619A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-07-15 1995-01-14 1995-07-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-07-15 1999-01-14 1999-07-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-07-15 2003-01-14 2003-07-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag